Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24272)

Formulation Name
Larotrectinib 20 mg/ml solution
Company
Bayer Healthcare Pharmaceuticals ; Loxo Oncology;
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Larotrectinib DM26CQR Solid tumour/cancer 2A00-2F9Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Glycerin E00026 753 Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Hydroxypropyl betadex E00697 Not Available Complexing agent; Modified-release agent; penetration agent; Solubilizing agent; Tonicity agent
Kyselina citronova E00014 311 Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
methylparaben E00149 7456 Antimicrobial preservative
Potassium sorbate E00566 23676745 Antimicrobial preservative
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Saccharose E00091 5988 Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium citrate dihydrate E00369 71474 Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sorbitan tristearate E00516 17800859 Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
Trisodium Phosphate E00284 24243 Other agent
Water E00035 962 Solvent